menu
    • menu

    Company profile for Arch Oncology

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arch Oncology is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. Our next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class. Our lead product candidate AO-176 is in a Phase 1 clinical tr...
    Arch Oncology is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. Our next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class. Our lead product candidate AO-176 is in a Phase 1 clinical trial for the treatment of patients with select solid tumors. In addition, we are advancing a number of pipeline programs, including anti-signal regulatory protein (SIRP) antibodies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arch OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2000 Sierra Point Parkway, Suite 700 Brisbane, CA 94005
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://archoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/archoncology
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arch Oncology Receives U.S. FDA ODD for AO-176 in Multiple Myeloma
    Arch Oncology Receives U.S. FDA ODD for AO-176 in Multiple Myeloma

    21 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/21/2370888/0/en/Arch-Oncology-Receives-U-S-FDA-Orphan-Drug-Designation-for-AO-176-a-Next-Generation-Anti-CD47-IgG2-Antibody-for-the-Treatment-of-Multiple-Myeloma.html

    GLOBENEWSWIRE
    21 Jan 2022
    Share Share
    Arch Oncology Strengthens Medical and Clinical Leadership Teams
    Arch Oncology Strengthens Medical and Clinical Leadership Teams

    02 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/02/2272784/0/en/Arch-Oncology-Strengthens-Medical-and-Clinical-Leadership-Teams-with-Key-Appointments.html

    GLOBENEWSWIRE
    02 Aug 2021
    Share Share
    Arch Oncology goes on hiring spree from AbbVie, BMS, Xencor
    Arch Oncology goes on hiring spree from AbbVie, BMS, Xencor

    02 Aug 2021

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/arch-oncology-boosts-medical-clinical-management-three-hires-from-abbvie-bms-xencor

    Kyle LaHucik FIERCEBIOTECH
    02 Aug 2021
    Share Share
    Arch Oncology Secures $105 Million Series C Financing
    Arch Oncology Secures $105 Million Series C Financing

    27 Apr 2021

    // PRESS RELEASE

    https://archoncology.com/arch-oncology-secures-105-million-series-c-financing/

    PRESS RELEASE
    27 Apr 2021
    Share Share
    Arch Oncology Announces Two New Preclinical Data Presentations
    Arch Oncology Announces Two New Preclinical Data Presentations

    11 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/fr/news-release/2021/03/10/2190881/0/en/Arch-Oncology-Announces-Two-New-Preclinical-Data-Presentations-on-Highly-Differentiated-Anti-CD47-Antibody-AO-176-at-AACR-2021.html

    GLOBENEWSWIRE
    11 Mar 2021
    Share Share
    Arch Oncology to Collaborate with Merck on Ph 1/2 Trial of Anti-CD47 Antibody
    Arch Oncology to Collaborate with Merck on Ph 1/2 Trial of Anti-CD47 Antibody

    09 Feb 2021

    // ARCHONCOLOGY

    https://archoncology.com/arch-oncology-to-collaborate-with-merck-on-phase-1-2-clinical-trial-of-anti-cd47-antibody-ao-176-in-combination-with-keytruda-pembrolizumab-in-patients-with-select-solid-tumors/

    ARCHONCOLOGY
    09 Feb 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search